Up a level |
Lampertico, Pietro, Mauss, Stefan, Persico, Marcello, Barclay, Stephen T, Marx, Steven, Lohmann, Kristina, Bondin, Mark, Zhang, ZhenZhen, Marra, Fiona ORCID: 0000-0003-1326-1149, Belperio, Pamela S et al (show 2 more authors)
(2020)
Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naive Patients with Compensated Cirrhosis.
ADVANCES IN THERAPY, 37 (9).
pp. 4033-4042.
Lampertico, Pietro, Mauss, Stefan, Persico, Marcello, Barclay, Stephen T, Marx, Steven, Lohmann, Kristina, Bondin, Mark, Zhang, ZhenZhen, Marra, Fiona ORCID: 0000-0003-1326-1149, Belperio, Pamela S et al (show 2 more authors)
(2020)
Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naive Patients with Compensated Cirrhosis (vol 37, pg 4033, 2020).
ADVANCES IN THERAPY, 37 (11).
pp. 4755-4756.
Lampertico, Pietro ORCID: 0000-0002-1026-7476, Berg, Thomas, Buti, Maria ORCID: 0000-0002-0732-3078, Pathil, Anita, Petersen, Joerg, Ryder, Stephen D, Zoulim, Fabien, Botros, Irina, Flaherty, John F, Jump, Belinda et al (show 4 more authors)
(2020)
Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus-infected patients with renal impairment: results from a 7-year, multicentre retrospective cohort study.
Alimentary pharmacology & therapeutics, 52 (3).
pp. 500-512.
Fan, Rong, Papatheodoridis, George, Sun, Jian, Innes, Hamish, Toyoda, Hidenori, Xie, Qing, Mo, Shuyuan, Sypsa, Vana, Guha, Indra Neil, Kumada, Takashi et al (show 32 more authors)
(2020)
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis.
JOURNAL OF HEPATOLOGY, 73 (6).
pp. 1368-1378.